InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Goeltz II Robert C., Chief Financial Officer. Director active across 1 company, notably Arcus Biosciences, Inc.. In total, 18 reports have been recorded. Split: 0 buy · 10 sells. Total volume traded: €854k. History available since 16 December 2021. The latest transaction was disclosed on 11 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Goeltz II Robert C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
7,763 shares@ US$25.630.0056% mcap31.6% of flowCommon StockSEC:0001653881-26-000005:0
24,000 shares0Common StockSEC:0001653881-26-000002:0
6,552 shares@ US$23.3812.4% of flowCommon StockSEC:0001610717-26-000002:0
6,702 shares@ US$21.884313.5% of flowCommon StockSEC:0001653881-25-000011:0
5,000 shares@ US$25.0013.5% of flowCommon StockSEC:0001653881-25-000007:0
5,000 shares@ US$20.000.0029% mcap16.1% of flowCommon StockSEC:0001653881-25-000005:0
37,000 shares0Common StockSEC:0001724521-25-000017:0
3,594 shares@ US$15.005.4% of flowCommon StockSEC:0001724521-25-000002:0
10,099 shares@ US$16.0816.2% of flowCommon StockSEC:0001724521-24-000180:0
22,000 shares0Common StockSEC:0001724521-24-000057:0
21,300 shares0Common StockSEC:0001724521-24-000030:0
2,004 shares@ US$20.003.8% of flowCommon StockSEC:0001724521-24-000009:0
2,749 shares@ US$17.744.7% of flowCommon StockSEC:0001724521-23-000067:0
4,049 shares@ US$20.047.9% of flowCommon StockSEC:0001209191-23-035740:0
34,000 shares0Common StockSEC:0001209191-23-004875:0
2,066 shares@ US$30.666.2% of flowCommon StockSEC:0001209191-22-061762:0
15,500 shares0Common StockSEC:0001209191-22-017984:0
354 shares@ US$39.59160.0004% mcap2.3% of flowCommon StockSEC:0001209191-21-070565:0
18 of 18 declarations
About Goeltz II Robert C.
Robert C. Goeltz II is the Chief Financial Officer at Arcus Biosciences, Inc. He is responsible for financial management and strategy for the company. His financial expertise is essential for supporting Arcus's growth and sustainability.
